Yaoling Medical Technology

Yaoling Medical Technology is a private Chinese AI-enabled clinical research technology and services company focused on digitizing clinical trials and real-world studies. Rather than developing its own therapeutics, the company operates as an AI-CRO and software provider for pharmaceutical companies, CROs, hospitals, and investigators. Its product suite supports source data capture, EDC-style workflows, subject follow-up, ePRO, randomization and trial supply management, endpoint adjudication, eTMF, analytics, and disease registry/research databases. The company emphasizes AI-assisted data structuring, remote monitoring, and real-world evidence generation to improve quality, efficiency, and cost in clinical research. Publicly visible evidence suggests it is commercially active in China and has sponsored or supported real-world studies involving marketed drugs such as denosumab and tandospirone.